159 related articles for article (PubMed ID: 35498853)
1. Exploring the binding mode and thermodynamics of inverse agonists against estrogen-related receptor alpha.
Karnati KR; Wang Y; Du Y
RSC Adv; 2020 Apr; 10(28):16659-16668. PubMed ID: 35498853
[TBL] [Abstract][Full Text] [Related]
2. Molecular Dynamics Simulations Based on 1-Phenyl-4-Benzoyl-1-Hydro-Triazole ERRα Inverse Agonists.
Gao Z; Du Y; Sheng X; Shen J
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33918423
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of human estrogen-related receptor alpha in complex with a synthetic inverse agonist reveals its novel molecular mechanism.
Kallen J; Lattmann R; Beerli R; Blechschmidt A; Blommers MJ; Geiser M; Ottl J; Schlaeppi JM; Strauss A; Fournier B
J Biol Chem; 2007 Aug; 282(32):23231-9. PubMed ID: 17556356
[TBL] [Abstract][Full Text] [Related]
4. Insights into the interaction mechanisms of estrogen-related receptor alpha (ERRα) with ligands via molecular dynamics simulations.
Li D; Cai Y; Teng D; Wu Z; Li W; Tang Y; Liu G
J Biomol Struct Dyn; 2020 Aug; 38(13):3867-3878. PubMed ID: 31498028
[TBL] [Abstract][Full Text] [Related]
5. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
[TBL] [Abstract][Full Text] [Related]
6. Computational insights into the interaction mechanisms of estrogen-related receptor alpha with endogenous ligand cholesterol.
Li D; Cai Y; Teng D; Li W; Tang Y; Liu G
Chem Biol Drug Des; 2019 Jul; 94(1):1316-1329. PubMed ID: 30811808
[TBL] [Abstract][Full Text] [Related]
7. Communication between the ERRalpha homodimer interface and the PGC-1alpha binding surface via the helix 8-9 loop.
Greschik H; Althage M; Flaig R; Sato Y; Chavant V; Peluso-Iltis C; Choulier L; Cronet P; Rochel N; Schüle R; Strömstedt PE; Moras D
J Biol Chem; 2008 Jul; 283(29):20220-30. PubMed ID: 18441008
[TBL] [Abstract][Full Text] [Related]
8. Discovery of New Estrogen-Related Receptor α Agonists via a Combination Strategy Based on Shape Screening and Ensemble Docking.
Li D; Jiang K; Teng D; Wu Z; Li W; Tang Y; Wang R; Liu G
J Chem Inf Model; 2022 Feb; 62(3):486-497. PubMed ID: 35041411
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha.
Huss JM; Kopp RP; Kelly DP
J Biol Chem; 2002 Oct; 277(43):40265-74. PubMed ID: 12181319
[TBL] [Abstract][Full Text] [Related]
10. Modulation of estrogen-related receptors subtype selectivity: Conversion of an ERRβ/γ selective agonist to ERRα/β/γ pan agonists.
Shahien M; Elagawany M; Sitaula S; Goher SS; Burris SL; Sanders R; Avdagic A; Billon C; Hegazy L; Burris TP; Elgendy B
Bioorg Chem; 2020 Sep; 102():104079. PubMed ID: 32683181
[TBL] [Abstract][Full Text] [Related]
11. The discovery of novel, potent ERR-alpha inverse agonists for the treatment of triple negative breast cancer.
Du Y; Song L; Zhang L; Ling H; Zhang Y; Chen H; Qi H; Shi X; Li Q
Eur J Med Chem; 2017 Aug; 136():457-467. PubMed ID: 28525844
[TBL] [Abstract][Full Text] [Related]
12. Investigation of binding mechanism and downregulation of elacestrant for wild and L536S mutant estrogen receptor-α through molecular dynamics simulation and binding free energy analysis.
Chinnasamy K; Saravanan M; Poomani K
J Comput Chem; 2020 Jan; 41(2):97-109. PubMed ID: 31602686
[TBL] [Abstract][Full Text] [Related]
13. A single nucleotide in an estrogen-related receptor alpha site can dictate mode of binding and peroxisome proliferator-activated receptor gamma coactivator 1alpha activation of target promoters.
Barry JB; Laganière J; Giguère V
Mol Endocrinol; 2006 Feb; 20(2):302-10. PubMed ID: 16150865
[TBL] [Abstract][Full Text] [Related]
14. Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand.
Willy PJ; Murray IR; Qian J; Busch BB; Stevens WC; Martin R; Mohan R; Zhou S; Ordentlich P; Wei P; Sapp DW; Horlick RA; Heyman RA; Schulman IG
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8912-7. PubMed ID: 15184675
[TBL] [Abstract][Full Text] [Related]
15. Andrographolide prevents bone loss via targeting estrogen-related receptor-α-regulated metabolic adaption of osteoclastogenesis.
Huang T; Fu X; Wang N; Yang M; Zhang M; Wang B; Chen T; Majaz S; Wang H; Wong CW; Liu J; Guan M
Br J Pharmacol; 2021 Nov; 178(21):4352-4367. PubMed ID: 34233019
[TBL] [Abstract][Full Text] [Related]
16. Advances in Medicinal Chemistry of Estrogen-related Receptor Alpha (ERRα) Inverse Agonists.
Zhang H; Du Y; Zheng Y; Lv H; Yan Z; Dong N; Zhu Y; Shen J
Curr Top Med Chem; 2023; 23(20):1952-1963. PubMed ID: 37190810
[TBL] [Abstract][Full Text] [Related]
17. [XCT790 inhibits rat vascular smooth muscle cells proliferation through down-regulating the expression of estrogen-related receptor alpha].
Lu YH; Li QY; Chen L; Shi XJ
Yao Xue Xue Bao; 2014 Feb; 49(2):190-7. PubMed ID: 24761608
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.
Kokabu T; Mori T; Matsushima H; Yoriki K; Kataoka H; Tarumi Y; Kitawaki J
Cell Oncol (Dordr); 2019 Apr; 42(2):223-235. PubMed ID: 30706380
[TBL] [Abstract][Full Text] [Related]
19. The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis.
Schreiber SN; Emter R; Hock MB; Knutti D; Cardenas J; Podvinec M; Oakeley EJ; Kralli A
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6472-7. PubMed ID: 15087503
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a Novel Class of ERRα Agonists.
Shinozuka T; Ito S; Kimura T; Izumi M; Wakabayashi K
ACS Med Chem Lett; 2021 May; 12(5):817-821. PubMed ID: 34055231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
